Filing Details
- Accession Number:
- 0000919574-18-007602
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-16 19:14:56
- Reporting Period:
- 2018-11-14
- Accepted Time:
- 2018-11-16 19:14:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1372514 | Eyegate Pharmaceuticals Inc | EYEG | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601086 | Armistice Capital, Llc | 510 Madison Avenue 7Th Floor New York NY 10022 | Yes | No | Yes | No | |
| 1633584 | Ltd. Fund Master Capital Armistice | C/O Dms Corporate Services Ltd. 20 Genesis Close, P.o. Box 314 Grand Cayman E9 KY1-1104 | No | No | Yes | No | |
| 1706140 | Steven Boyd | C/O Armistice Capital, Llc 510 Madison Avenue, 7Th Floor New York NY 10022 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-14 | 5,129 | $0.45 | 16,807,629 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-14 | 0 | $0.00 | 16,807,629 | No | 4 | P | Indirect | See Footnote |
| Common Stock | Acquisiton | 2018-11-14 | 0 | $0.00 | 16,807,629 | No | 4 | P | Indirect | See Footnote |
| Common Stock | Acquisiton | 2018-11-14 | 50,000 | $0.41 | 16,857,629 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-14 | 0 | $0.00 | 16,857,629 | No | 4 | P | Indirect | See Footnote |
| Common Stock | Acquisiton | 2018-11-14 | 0 | $0.00 | 16,857,629 | No | 4 | P | Indirect | See Footnote |
| Common Stock | Acquisiton | 2018-11-15 | 126,735 | $0.43 | 16,984,364 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-15 | 0 | $0.00 | 16,984,364 | No | 4 | P | Indirect | See Footnote |
| Common Stock | Acquisiton | 2018-11-15 | 0 | $0.00 | 16,984,364 | No | 4 | P | Indirect | See Footnote |
| Common Stock | Acquisiton | 2018-11-16 | 178,136 | $0.47 | 17,162,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-16 | 0 | $0.00 | 17,162,500 | No | 4 | P | Indirect | See Footnote |
| Common Stock | Acquisiton | 2018-11-16 | 0 | $0.00 | 17,162,500 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants | Acquisiton | 2018-11-16 | 625,000 | $0.13 | 625,000 | $0.32 |
| Common Stock | Warrants | Acquisiton | 2018-11-16 | 0 | $0.00 | 0 | $0.32 |
| Common Stock | Warrants | Acquisiton | 2018-11-16 | 0 | $0.00 | 0 | $0.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 625,000 | 2018-04-17 | 2023-04-17 | No | 4 | P | Direct |
| 625,000 | 2018-04-17 | 2023-04-17 | No | 4 | P | Indirect |
| 625,000 | 2018-04-17 | 2023-04-17 | No | 4 | P | Indirect |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants | $0.32 | 2018-04-17 | 2023-04-17 | 5,468,750 | 5,468,750 | Direct |
| Common Stock | Warrants | $0.32 | 2018-04-17 | 2023-04-17 | 0 | 5,468,750 | Indirect |
| Common Stock | Warrants | $0.32 | 2018-04-17 | 2023-04-17 | 0 | 5,468,750 | Indirect |
| Common Stock | Warrants | $1.50 | 2017-06-14 | 2022-06-14 | 2,000,000 | 2,000,000 | Direct |
| Common Stock | Warrants | $1.50 | 2017-06-14 | 2022-06-14 | 0 | 2,000,000 | Indirect |
| Common Stock | Warrants | $1.50 | 2017-06-14 | 2022-06-14 | 0 | 2,000,000 | Indirect |
| Common Stock | Warrants | $0.32 | 2018-04-17 | 2023-04-17 | 15,937,500 | 15,937,500 | Direct |
| Common Stock | Warrants | $0.32 | 2018-04-17 | 2023-04-17 | 0 | 15,937,500 | Indirect |
| Common Stock | Warrants | $0.32 | 2018-04-17 | 2023-04-17 | 0 | 15,937,500 | Indirect |
| Common Stock | Series C Convertible Preferred Stock | $0.32 | 2018-04-17 | 12,787,500 | 12,787,500 | Direct | |
| Common Stock | Series C Convertible Preferred Stock | $0.32 | 2018-04-17 | 0 | 12,787,500 | Indirect | |
| Common Stock | Series C Convertible Preferred Stock | $0.32 | 2018-04-17 | 0 | 12,787,500 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-04-17 | 5,468,750 | 5,468,750 | Direct |
| 2023-04-17 | 0 | 5,468,750 | Indirect |
| 2023-04-17 | 0 | 5,468,750 | Indirect |
| 2022-06-14 | 2,000,000 | 2,000,000 | Direct |
| 2022-06-14 | 0 | 2,000,000 | Indirect |
| 2022-06-14 | 0 | 2,000,000 | Indirect |
| 2023-04-17 | 15,937,500 | 15,937,500 | Direct |
| 2023-04-17 | 0 | 15,937,500 | Indirect |
| 2023-04-17 | 0 | 15,937,500 | Indirect |
| 12,787,500 | 12,787,500 | Direct | |
| 0 | 12,787,500 | Indirect | |
| 0 | 12,787,500 | Indirect |
Footnotes
- The reported securities are directly owned by Armistice Capital Master Fund Ltd.
- The reported securities are directly owned by Armistice Capital Master Fund Ltd., a Cayman Islands corporation, and may be deemed to be indirectly beneficially owned by Armistice Capital, LLC, as the investment manager of Armistice Capital Master Fund Ltd. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital, LLC and Director of Armistice Capital Master Fund Ltd. Armistice Capital, LLC and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- These warrants are currently exercisable, subject to a blocker provision that prevents Armistice Capital Master Fund, Ltd. from exercising the warrants if it would be more than a 9.99% beneficial owner of the Common Shares following such exercise.
- These warrants are currently excercisable, subject to a blocker provision that prevents Armistice Capital Master Fund, Ltd. from exercising the warrants if it would be more than a 4.99% beneficial owner of the Common Shares following such exercise.
- The Series C Convertible Preferred Stock has no expiration date and is convertible at any time at the option of Armistice Capital Master Fund, Ltd., subject to a blocker provision that prevents Armistice Capital Master Fund, Ltd. from converting the Series C Convertible Preferred Stock into Common Shares if it would be more than a 4.99% beneficial owner of the Common Shares following such conversion.
- This constitutes the weighted average purchase price. The prices range from $0.4305 to $0.4431. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- This constitutes the weighted average purchase price. The prices range from $0.4615 to $0.4834. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
